title: Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
abstract: Atopic dermatitis (AD) is a chronic, pruritic, inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in the management and care of AD, providing updated and expanded recommendations based on the available evidence. In this first of 4 sections, methods for the diagnosis and monitoring of disease, outcomes measures for assessment, and common clinical associations that affect patients with AD are discussed. Known risk factors for the development of disease are also reviewed.
authors.affiliation: Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, California.
authors.forename: Lawrence F
authors.initials: LF
authors.lastname: Eichenfield
authors.affiliation: Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, California.
authors.forename: Wynnis L
authors.initials: WL
authors.lastname: Tom
authors.affiliation: Department of Dermatology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Chamlin
authors.affiliation: Department of Dermatology, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
authors.forename: Steven R
authors.initials: SR
authors.lastname: Feldman
authors.affiliation: Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
authors.forename: Jon M
authors.initials: JM
authors.lastname: Hanifin
authors.affiliation: Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
authors.forename: Eric L
authors.initials: EL
authors.lastname: Simpson
authors.affiliation: Department of Dermatology, University of California San Francisco, San Francisco, California.
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Berger
authors.affiliation: Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: James N
authors.initials: JN
authors.lastname: Bergman
authors.affiliation: Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
authors.forename: David E
authors.initials: DE
authors.lastname: Cohen
authors.affiliation: Department of Dermatology, Case Western University, Cleveland, Ohio.
authors.forename: Kevin D
authors.initials: KD
authors.lastname: Cooper
authors.affiliation: Department of Dermatology, University of California San Francisco, San Francisco, California.
authors.forename: Kelly M
authors.initials: KM
authors.lastname: Cordoro
authors.affiliation: Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Dawn M
authors.initials: DM
authors.lastname: Davis
authors.affiliation: Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
authors.forename: Alfons
authors.initials: A
authors.lastname: Krol
authors.affiliation: Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
authors.forename: David J
authors.initials: DJ
authors.lastname: Margolis
authors.affiliation: Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
authors.forename: Amy S
authors.initials: AS
authors.lastname: Paller
authors.affiliation: Division of Dermatology, Fletcher Allen Health Care, Burlington, Vermont.
authors.forename: Kathryn
authors.initials: K
authors.lastname: Schwarzenberger
authors.affiliation: Private practice, Fairfax, Virginia.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Silverman
authors.affiliation: Centre of Evidence-Based Dermatology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
authors.forename: Hywel C
authors.initials: HC
authors.lastname: Williams
authors.affiliation: Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama.
authors.forename: Craig A
authors.initials: CA
authors.lastname: Elmets
authors.affiliation: National Eczema Association, San Rafael, California.
authors.forename: Julie
authors.initials: J
authors.lastname: Block
authors.affiliation: American Academy of Dermatology, Schaumburg, Illinois.
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Harrod
authors.affiliation: American Academy of Dermatology, Schaumburg, Illinois. Electronic address: wsmithbegolka@aad.org.
authors.forename: Wendy
authors.initials: W
authors.lastname: Smith Begolka
authors.affiliation: Department of Dermatology, Seattle Children's Hospital, Seattle, Washington.
authors.forename: Robert
authors.initials: R
authors.lastname: Sidbury
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D015415:Biomarkers / Q000097:blood; D002648:Child; D002908:Chronic Disease; D015897:Comorbidity; D003876:Dermatitis, Atopic / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D019317:Evidence-Based Medicine; D005260:Female; D000091344:Filaggrin Proteins; D006801:Humans; D008297:Male; D010808:Physical Examination; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011788:Quality of Life; D018570:Risk Assessment; D012720:Severity of Illness Index; D055815:Young Adult
chemical_list: D015415:Biomarkers; C000717249:FLG protein, human; D000091344:Filaggrin Proteins
keywords: AAD; AD; ADHD; American Academy of Dermatology; CDLQI; Children's Dermatology Life Quality Index; DFI; DLQI; Dermatitis Family Impact; Dermatology Life Quality Index; EASI; Eczema Area and Severity Index; FLG; GREAT; Global Resource for Eczema Trials; IGA; IL; ISAAC; IgE; International Study of Asthma and Allergies in Childhood; Investigator's Global Assessment; MDC; POEM; Patient-Oriented Eczema Measure; SASSAD; SCORAD; SCORing Atopic Dermatitis; SORT; Six Area, Six Sign Atopic Dermatitis; TARC; TISS; Three-Item Severity Scale; UK; United Kingdom; assessment scales; atopic dermatitis; attention deficit hyperactivity disorder; biomarkers; clinical associations; criteria; diagnosis; filaggrin; immunoglobulin E; interleukin; macrophage-derived chemoattractant; risk factors; strength of recommendation taxonomy; thymus and activation-regulated chemokine